default author photo

Guillermo Garcia-Manero

University of Texas at Houston - Department of Leukemia

Houston, TX

United States

SCHOLARLY PAPERS

2

DOWNLOADS

134

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Pharmacokinetic- and Pharmacodynamic-Guided Phase 1 Study of an Oral Fixed-Dose Combination of Decitabine and the Cytidine Deaminase Inhibitor Cedazuridine in Myelodysplastic Syndromes

Number of pages: 128 Posted: 22 Nov 2018
Vanderbilt University - Vanderbilt-Ingram Cancer Center, University of Chicago - Medical Center, Harvard University - Massachusetts General Hospital, Harvard University - Dana-Farber Cancer Institute, The John Hopkins Hospital, Medical College of Wisconsin, Rutgers, The State University of New Jersey - Hackensack University Medical Center, Horizon Oncology Center, University of Texas at Houston - Department of Leukemia, Astex Pharmaceuticals, Inc., Astex Pharmaceuticals, Inc., Astex Pharmaceuticals, Inc. and University of Texas at Houston - Department of Leukemia
Downloads 89 (747,755)

Abstract:

Loading...

DNA methyltransferase, Myelodysplastic syndrome, Chronic myelomonocytic leukemia, Oral therapy

2.

A Phase II Study of Omacetaxine Mepesuccinate for Patients with Higher-Risk Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia after Failure of Hypomethylating Agents

Number of pages: 56 Posted: 19 Jul 2018
University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Leukemia and University of Texas at Houston - Department of Leukemia
Downloads 45 (1,133,231)

Abstract:

Loading...

Myelodysplastic syndromes, chronic myelomonocytic leukemia, hypomethylating agents, omacetaxine mepesuccinate, homoharringtonine